Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma, Pancreatic Ductal

Explore clinical trials studying Adenocarcinoma, Pancreatic Ductal. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Adenocarcinoma, Pancreatic Ductal trial results

Recruiting

A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

NCT05968326

Conditions
Adenocarcinoma, Adenocarcinoma, Pancreatic Ductal, Carcinoma, +3 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Cancer Center Newport Beach, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • University of California Los Angeles Santa Monica, California, United States
View all 89 locations
View Trial Details

Related conditions